Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia

@article{Roy2004BenefitsAR,
  title={Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia},
  author={S. N. Roy and Siladitya Bhattacharya},
  journal={Drug Safety},
  year={2004},
  volume={27},
  pages={75-90}
}
  • S. N. Roy, Siladitya Bhattacharya
  • Published 2004
  • Medicine
  • Drug Safety
    • Menorrhagia affects the lives of many women. The assessment of menstrual flow is highly subjective and gauging the severity of the condition by objective assessment of menstrual blood loss is impractical. In treating menorrhagia, the primary aim should be to improve quality of life. Women are willing to undergo quite invasive treatment in order to achieve this. Drug therapy is the initial treatment of choice and the only option for those who wish to preserve their reproductive function. Despite… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    48 Citations
    Highly Influencial Citations
    1
    Background Citations
    11
    Methods Citations
    1
    48 Citations
    Citation Type

    Citation Type

    Medical management of menorrhagia
    • 3
    Menorrhagia, mechanisms and targeted therapies
    • 19
    An expert review and commentary on the efficacy and safety of tranexamic acid for the treatment of heavy menstrual bleeding
    • 1
    A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.
    • 4
    A Benefit-Risk Review of Systemic Haemostatic Agents
    • 53
    Management of Menorrhagia Associated with Chemotherapy‐Induced Thrombocytopenia in Women with Hematologic Malignancy
    • 21
    Efficacy and Safety of Ormeloxifene versus low dose OCP in the treatment of Abnormal Uterine Bleeding (AUB)
    • PDF
    Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.
    • 101
    • PDF
    A Comparative Trial of the Efficacy of Mefenamic Acid and Tranexamic Acid for Treatment of Menorrhagia Induced by Copper T-380A IUD
    • 1
    • PDF
    Antifibrinolytics in women with menorrhagia.
    • 22

    References

    SHOWING 1-10 OF 90 REFERENCES
    Risk-Benefit Assessment of Drugs Used for the Treatment of Menstrual Disorders
    • 24
    Medical management of menorrhagia
    • 1
    Medical management of menorrhagia
    • 26
    Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice.
    • 108
    Efficacy of Mefenamic Acid in Patients with a Complaint of Menorrhagia
    • 103
    Management of cyclical menorrhagia with prostaglandin synthetase inhibitor.
    • 17
    Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid
    • 212
    A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    • 29
    REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO
    • 72
    The Effects of Mefenamic Acid and Norethisterone on Measured Menstrual Blood Loss
    • 94